2seventy bio Stock (NASDAQ: TSVT) stock price, news, charts, stock research, profile.
Open | $5.010 |
Close | - |
Volume / Avg. | 15.365K / 1.447M |
Day Range | 4.950 - 5.050 |
52 Wk Range | 1.535 - 12.690 |
Market Cap | $256.556M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 13.42% |
Days to Cover | 3.28 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of 2seventy bio (NASDAQ: TSVT) through any online brokerage.
Other companies in 2seventy bio’s space includes: Adverum Biotechnologies (NASDAQ:ADVM), Inozyme Pharma (NASDAQ:INZY), Inovio Pharmaceuticals (NASDAQ:INO), Adaptimmune Therapeutics (NASDAQ:ADAP) and Opthea (NASDAQ:OPT).
The latest price target for 2seventy bio (NASDAQ: TSVT) was reported by Citigroup on Monday, April 8, 2024. The analyst firm set a price target for 12.00 expecting TSVT to rise to within 12 months (a possible 140.00% upside). 17 analyst firms have reported ratings in the last year.
The stock price for 2seventy bio (NASDAQ: TSVT) is $5 last updated April 17, 2024 at 8:22 AM EDT.
There are no upcoming dividends for 2seventy bio.
2seventy bio’s Q1 earnings are confirmed for Wednesday, May 1, 2024.
There is no upcoming split for 2seventy bio.
2seventy bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.